Lead Product(s) : L-Arginine Hydrochloride API
Therapeutic Area : Endocrinology
Study Phase : Phase I
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls
Details : Arginine HCl is a Other Small Molecule drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Diabetes Mellitus, Type 2.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
October 19, 2012
Lead Product(s) : L-Arginine Hydrochloride API
Therapeutic Area : Endocrinology
Highest Development Status : Phase I
Sponsor : Pfizer Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
